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Previously, we found caveolin (CAV-1) expressed by transfection in cultured 
lymphocytes induced caveolae formation and targeted the glycolytic enzyme 
phosphofructokinase (PFK) to the membrane. We also found CAV-1 targets other 
glycolytic enzymes such as aldolase (ALD)and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) to the plasma membrane in the CAV-1 transfected 
lymphocytes. Here we hypothesized that if a mutant CAV-1 (which has essential 
aromatic residues in the caveolin scaffolding domain (CSD) mutated) is expressed in 
the lymphocyte then colocalization of the glycolytic enzyme PFK with CAV-1 will be 
reduced. We tested this hypothesis by comparing the colocalization of CAV-1 with the 
glycolytic enzymes PFK, ALD and GAPDH in lymphocytes which expressed either a 
wild type CAV-1 (WT) or a mutant CAV-1 which had either one mutation (SM) or two 
mutations (DM) in the CSD. Colocalization analysis by confocal microscopy of cells 
immunoassayed for CAV-1 and ALD was 76.59% in lymphocytes transfected with CAV-
1 WT, 23.96% in lymphocytes transfected with CAV-1 SM, and 58.74% in the 
lymphocytes transfected with CAV-1 DM. Analysis of colocalization of the enzymes 
PFK, GAPDH, and ALD with CAV-1 averaged 65.17% for the CAV-1 WT cells, 49.29% 
for the CAV-1 SM cells and 50.81% for the CAV-1 DM cells. The shift in distribution of 
glycolytic enzymes and CAV-1 in the CAV-1 WT, the CAV-1 SM or DM CAV-1 types 
indicates that a single mutation to the CSD reduces membrane targeting of glycolytic 
enzymes, and two mutations in the CSD produces retention of CAV-1 in the cytosol. 
These results suggest that an intact CSD domain is essential to the CAV-1 targeting of 
glycolytic enzymes to the membrane.  
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